Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-15,000
Closed -$4K 3946
2023
Q3
$4K Sell
15,000
-4,000
-21% -$91.5K ﹤0.01% 2966
2023
Q2
$32K Buy
19,000
+15,000
+375% +$285K ﹤0.01% 1563
2023
Q1
$13K Buy
+4,000
New +$77.7K ﹤0.01% 2155
2022
Q4
Sell
-3,000
Closed -$11K 4778
2022
Q3
$11K Buy
+3,000
New +$71.9K ﹤0.01% 3069
2020
Q2
Sell
-10,600
Closed -$113K 4611
2020
Q1
$113K Buy
+10,600
New +$251K 0.01% 1274
2019
Q1
Sell
-6,000
Closed -$42K 4372
2018
Q4
$42K Sell
6,000
-2,000
-25% -$31.9K ﹤0.01% 1588
2018
Q3
$22K Buy
8,000
+4,500
+129% +$102K ﹤0.01% 2178
2018
Q2
$17K Buy
+3,500
New +$90.1K ﹤0.01% 2299
2017
Q4
Sell
-9,500
Closed -$2K 5358
2017
Q3
$2K Buy
9,500
+8,800
+1,257% +$168K ﹤0.01% 5086
2017
Q2
$4K Sell
700
-65,900
-99% -$1.13M ﹤0.01% 5021
2017
Q1
$21K Buy
+66,600
New +$1.03M ﹤0.01% 3270
2016
Q3
Sell
-4,800
Closed -$15K 6989
2016
Q2
$15K Buy
4,800
+4,300
+860% +$50.2K ﹤0.01% 3669
2016
Q1
$3K Sell
500
-5,600
-92% -$73.6K ﹤0.01% 5277
2015
Q4
$12K Buy
+6,100
New +$107K ﹤0.01% 3940

Other funds holding INSM

Cutler Group's INSM Position: Q4 2023 in Review

Cutler Group sold out of Insmed (INSM) in Q4 2023, closing a stake of 1,600 shares — an estimated $40K sold.

Cutler Group first reported a position in INSM in Q4 2015 and held it in 15 quarters. The position peaked at $144K in Q3 2017. 271 funds tracked by Wall St. Rank hold INSM as of Q4 2023.

  • Cutler Group reported no remaining Insmed position as of Q4 2023 after selling out during the quarter.
  • Cutler Group sold 1,600 Insmed shares in Q4 2023, an estimated $40K.
  • Cutler Group first reported a position in Insmed in Q4 2015 and held it in 15 quarters.
  • Cutler Group's Insmed position peaked at $144K in Q3 2017.
  • 271 funds tracked by Wall St. Rank held Insmed as of Q4 2023.

Based on Cutler Group's 13F filing for Q4 2023, filed 18 Jan 2024.